Home  >  Products  >  GLT25D2 (glycosyltransferase 25 domain containing 2 ) Blocking Peptide (the C terminal of GLT25D2)(100ug)
GLT25D2 (glycosyltransferase 25 domain containing 2 ) Blocking Peptide (the C terminal of GLT25D2)(100ug)

GLT25D2 (glycosyltransferase 25 domain containing 2 ) Blocking Peptide (the C terminal of GLT25D2)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GLT25D2 Antibody (ARP67518_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67518
Size: 100ug
Weight: 69kDa
Gene: 23127
Format: Lyophilized powder
Target: GLT25D2 has a beta-galactosyltransferase activity and transfers beta-galactose to hydroxylysine residues on collagen.
Alternative names: C1orf17